Oppenheimer Initiates Coverage On Praxis Precision Medicine with Outperform Rating, Announces Price Target of $134
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer has initiated coverage on Praxis Precision Medicine (NASDAQ:PRAX) with an Outperform rating and a price target of $134.
August 05, 2024 | 10:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer has initiated coverage on Praxis Precision Medicine with an Outperform rating and a price target of $134.
The initiation of coverage with an Outperform rating and a high price target of $134 by a reputable analyst at Oppenheimer is likely to positively impact the stock price of Praxis Precision Medicine in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100